<p>NORCROSS, Ga., Sept. 26, 2023 (GLOBE NEWSWIRE) — Galectin Therapeutics, Inc. (NASDAQ: GALT), the leading developer of therapeutics that target galectin-3, today announced it will partic
<p>INFINOX, a leading provider of CFD trading solutions, is pleased to announce the appointment of Robert Collins as its new Head of Trading. Based in the London office, Robert will lead INFINOX
<p>The global asset that dominated the conversation in much of 2023 and particularly in Q4 was the 10-year Treasury note. However after a tumultuous year, it finishes nearly unchanged.</p>
Leave a Comment